Literature DB >> 3956214

Outcome of pediatric patients with multiple organ system failure.

J D Wilkinson, M M Pollack, U E Ruttimann, N L Glass, T S Yeh.   

Abstract

The association of multiple organ system failure (MOSF) with mortality was investigated in 831 consecutive admissions to a pediatric ICU. The incidence of MOSF (at least two organ system failures, OSF) was 27%. Of the 62 nonsurvivors, 60 (97%) had MOSF. The mortality for patients with MOSF was 54%, compared to a mortality of 0.3% for patients without MOSF. Mortality increased directly with increasing number of OSF (p less than .0001). The mortality was 1% for one OSF, 11% for two OSF, 50% for three OSF, and 75% for four OSF. Comparison of these results with data from adult ICU patients indicates that the mortality and clinical course of MOSF in children is distinct from adults. MOSF is significantly associated with mortality in pediatric patients; however, it is not sufficiently discriminating to determine continuation or withdrawal of ICU support.

Entities:  

Mesh:

Year:  1986        PMID: 3956214     DOI: 10.1097/00003246-198604000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  61 in total

1.  Acquired immunoparalysis in paediatric intensive care: prospective observational study.

Authors:  M Peters; A Petros; G Dixon; D Inwald; N Klein
Journal:  BMJ       Date:  1999-09-04

2.  Outcome of oncology patients in the pediatric intensive care unit.

Authors:  Y Sivan; P H Schwartz; T Schonfeld; I J Cohen; C J Newth
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Epidemiology and peculiarities of pediatric multiple organ dysfunction syndrome in New Delhi, India.

Authors:  Praveen Khilnani; Devajit Sarma; Jerry Zimmerman
Journal:  Intensive Care Med       Date:  2006-09-15       Impact factor: 17.440

4.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum.

Authors:  Hector R Wong; Natalie Cvijanovich; Geoffrey L Allen; Richard Lin; Nick Anas; Keith Meyer; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Thomas P Shanley
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

5.  Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.

Authors:  Esra Sevketoglu; Dincer Yildizdas; Ozden Ozgur Horoz; Hasan Serdar Kihtir; Tanil Kendirli; Suleyman Bayraktar; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2014-10       Impact factor: 3.624

6.  Mechanical ventilation in bone marrow transplanted children; do they benefit?

Authors:  H T Henneveld; N M Wulffraat; R J Gemke; A J van Vught
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

Review 7.  Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects.

Authors:  B Tabarki; A Coffiniéres; P Van Den Bergh; G Huault; P Landrieu; G Sébire
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

8.  Use of oral clonidine for sedation in ventilated paediatric intensive care patients.

Authors:  Sara Arenas-López; Shelley Riphagen; Shane M Tibby; Andrew Durward; Steve Tomlin; Graham Davies; Ian A Murdoch
Journal:  Intensive Care Med       Date:  2004-06-10       Impact factor: 17.440

9.  GAP between knowledge and skills for the implementation of the ACCM/PALS septic shock guidelines in India: is the bridge too far?

Authors:  Indumathy Santhanam; Niranjan Kissoon; S R Kamath; Suchitra Ranjit; Jayanthi Ramesh; Janani Shankar
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun

10.  Identification of pediatric septic shock subclasses based on genome-wide expression profiling.

Authors:  Hector R Wong; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Douglas F Willson; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Marie Monaco; Kelli Odom; Thomas P Shanley
Journal:  BMC Med       Date:  2009-07-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.